AI Proteins, Inc.
Engineered miniproteins designed with AI and synthetic biology for therapeutic biologics
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2021
- Latest Form D
- $5M, Apr 2024
- Total capital
- $24.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $24.6M
- 3 Form D · last Apr 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 14 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$5M
- Private capital raisedForm D · SEC · 2nd filing$8.3M
- Private capital raisedForm D · SEC · 1st filing$11.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Arthur A. BeckerDirectorNamed in SEC Form D filings
- Bill A. McKeeDirectorNamed in SEC Form D filings
- Bobby SandageDirectorNamed in SEC Form D filings
- Bruce EvansDirectorNamed in SEC Form D filings
- Carl A. NovinaDirectorNamed in SEC Form D filings
- Chris BahlExecutive Officer, DirectorNamed in SEC Form D filings
Show all 18 people
- Dominique A. VerhelleDirectorNamed in SEC Form D filings
- Drew DennisonDirectorNamed in SEC Form D filings
- Elena A. ProkupetsDirectorNamed in SEC Form D filings
- Geoff A. MeyersonDirectorNamed in SEC Form D filings
- Julia A. NovinaExecutive OfficerNamed in SEC Form D filings
- Malcolm SalterDirectorNamed in SEC Form D filings
- Marc A. CohenExecutive Officer, DirectorNamed in SEC Form D filings
- Mark AllesDirectorNamed in SEC Form D filings
- Namandje A. BumpusDirectorNamed in SEC Form D filings
- Noah BeermanExecutive OfficerNamed in SEC Form D filings
- Todd KaloudisDirectorNamed in SEC Form D filings
- Wendy DwyerExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 14- PendingSynthetic CD123 Binding Proteins, Manufacture, And Uses ThereofUSPTOApplication PCTUS2025032214
- PendingSynthetic LILRB4-BINDING Proteins, Manufacture, And Uses ThereofUSPTOApplication PCTUS2025019794
- PendingSynthetic Multivalent Fusion Proteins, Manufacture, And Uses ThereofUSPTOApplication PCTUS2025019826
Show all 14 patent records
- Synthetic CD123 Binding Proteins, Manufacture, And Uses ThereofApplication PCTUS2025032214Pending
- Synthetic LILRB4-BINDING Proteins, Manufacture, And Uses ThereofApplication PCTUS2025019794Pending
- Synthetic Multivalent Fusion Proteins, Manufacture, And Uses ThereofApplication PCTUS2025019826Pending
- Synthetic CD16A Binding Proteins, Manufacture, And Uses ThereofApplication PCTUS2025019796Pending
- Methods And Systems For Characterizing Structural Features Of A ProteinApplication PCTUS2025013015Pending
- Synthetic GLP-1R Binding Proteins, Manufacture, And Uses ThereofApplication PCTUS2024055673Pending
- Synthetic CD123 Binding Proteins, Manufacture, And Uses ThereofApplication 63656568Pending
- Synthetic LILRB4 Binding Proteins, Manufacture, And Uses ThereofApplication 63566178Pending
- Synthetic Multivalent Fusion Proteins, Manufacture, And Uses ThereofApplication 63566182Pending
- SYNTHETIC CD16a BINDING PROTEINS, MANUFACTURE, AND USES THEREOFApplication 63566180Pending
- Methods And Systems For Characterizing Structural Features Of A ProteinApplication 63624960Pending
- Synthetic GLP-1R Binding Proteins, Manufacture, And Uses ThereofApplication 63598248Pending
- Synthetic TNFR1 Binding Proteins, Manufacture, And Uses ThereofApplication 63505423Pending
- Synthetic GLP-1R Binding Proteins, Manufacture, And Uses ThereofApplication 19587045Pending
Related companies, and why
- NurExone Biologic Inc.Similar federal contract value in Biotech · null in contracts
- Beta Cat Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Outpost Medicine, LLCSimilar federal contract value in Biotech · null in contracts
- FibroGenSimilar federal contract value in Biotech · null in contracts
- Dialectic Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Propanc Biopharma, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .